Stock Taper Underlying Net Income: CAD 1.12 billion, up from CAD 1.02 billion YoY.
Underlying EPS: CAD 2.02, a 13% increase from the previous year.
Reported Net Income: CAD 1.01 billion, compared to CAD 716 million YoY.
Underlying Return on Equity (ROE): 19.1%.
LICAT Ratio: 145%, indicating strong capital position.
Insurance Sales: Increased by 20%, driven by growth in Asia and the U.S.
Asset Management Net Flows: CAD 16.3 billion, boosted by private credit fundraising and a significant mandate win in India.
Digital Transformation: Progress in AI initiatives, including a new AI platform and enhanced client services in various regions.
Asset Management: Successful integration of Sun Life Asset Management as a unified platform, with strong fundraising and deployment activities.
Regional Performance:
Canada: Record underlying net income of CAD 427 million, up 23% YoY, with strong growth in insurance and wealth management.
Asia: Underlying net income rose 21%, with significant sales growth in Hong Kong and Indonesia.
U.S.: Strong performance in medical stop loss and health solutions, with a 15% increase in underlying net income.
SLF expects to continue delivering sustainable, broad-based earnings growth, with underlying EPS growth above the target of 10% and ROE approaching the 20% target.
The company remains focused on executing its Client Impact Strategy and is well-positioned for future growth, particularly in asset management and health solutions.
MFS Outflows: Elevated outflows in the asset management segment due to industry-wide pressures on active U.S. equity managers.
Dental Business: Continued challenges in the Medicaid segment, with a 9% decline in membership and zero sales in the latest quarter, indicating a strategic shift away from unprofitable contracts.
Competitive Pressures: The Hong Kong market remains competitive, necessitating pricing adjustments to maintain market share, which could impact margins.
U.S. Stop Loss Business: Management acknowledged seasonal reserve builds affecting profitability but maintained that overall performance aligns with expectations. They emphasized a disciplined approach to pricing and underwriting.
Dental Strategy: Management is focused on shifting towards a more profitable mix in the dental business, with expectations of gradual improvement over the next one to two years.
Asia's High Net Worth Business: Management indicated that while the high net worth segment is performing well, regulatory changes in China are not expected to significantly impact sales momentum.
SLC Management: Confidence in achieving medium-term growth targets of 20% for underlying earnings, driven by strong market demand and improved operational efficiencies. Overall, Sun Life Financial reported strong financial results in Q2 2026, with significant growth across various segments, although challenges in specific areas like MFS and the dental business were acknowledged. The company remains optimistic about its strategic initiatives and future growth potential.
SOURCE: Q2 2026 EARNINGS CALL TRANSCRIPT